Abstract
Urinary N-acetyl-beta-D-glucosaminidase (NAG) activities were assayed in every urine void throughout 24 hours in 17 normal people and in four patients with renal disease. The variation in NAG activity due to changing rates of urine flow was almost eliminated by factoring enzyme activity by the urinary creatinine concentration. Random samples of urine may thus be used for assay. The results of NAG assay in 36 patients with acute and chronic renal diseases showed that NAG was a sensitive indicator of renal damage. This simple test may be valuable in detecting or monitoring renal disease.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hultberg B., Nordén N., Ockerman P. A. Urinary excretion of acid hydrolases in disease. Scand J Clin Lab Invest. 1972 Oct;30(2):215–219. doi: 10.3109/00365517209081113. [DOI] [PubMed] [Google Scholar]
- LEABACK D. H., WALKER P. G. Studies on glucosaminidase. 4. The fluorimetric assay of N-acetyl-beta-glucosaminidase. Biochem J. 1961 Jan;78:151–156. doi: 10.1042/bj0780151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ROSALKI S. B., WILKINSON J. H. Urinary lactic dehydrogenase in renal disease. Lancet. 1959 Sep 12;2(7098):327–328. doi: 10.1016/s0140-6736(59)91363-7. [DOI] [PubMed] [Google Scholar]
- Sandman R., Margules R. M., Kountz S. L. Urinary lysosomal glycosidases after renal allotransplantation: correlation of enzyme excretion with allograft rejection and ischemia. Clin Chim Acta. 1973 May 30;45(4):349–359. doi: 10.1016/0009-8981(73)90035-1. [DOI] [PubMed] [Google Scholar]
- WACKER W. E., DORFMAN L. E. Urinary lactic dehydrogenase activity. I. Screening method for detection of cancer of kidneys and bladder. JAMA. 1962 Sep 15;181:972–978. [PubMed] [Google Scholar]
- Wellwood J. M., Ellis B. G., Hall J. H., Robinson D. R., Thompson A. E. Early warning of rejection? Br Med J. 1973 May 5;2(5861):261–265. doi: 10.1136/bmj.2.5861.261. [DOI] [PMC free article] [PubMed] [Google Scholar]